Melanie J Herman - Net Worth and Insider Trading

Melanie J Herman Net Worth

The estimated net worth of Melanie J Herman is at least $398,080 dollars as of 2024-11-13. Melanie J Herman is the Director of Accounting of Ligand Pharmaceuticals Inc and owns about 3,297 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $398,080. Details can be seen in Melanie J Herman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Melanie J Herman has not made any transactions after 2016-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Melanie J Herman

To

Melanie J Herman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Melanie J Herman owns 1 companies in total, including Ligand Pharmaceuticals Inc (LGND) .

Click here to see the complete history of Melanie J Herman’s form 4 insider trades.

Insider Ownership Summary of Melanie J Herman

Ticker Comapny Transaction Date Type of Owner
LGND Ligand Pharmaceuticals Inc 2016-05-18 Director of Accounting

Melanie J Herman Latest Holdings Summary

Melanie J Herman currently owns a total of 1 stock. Melanie J Herman owns 3,297 shares of Ligand Pharmaceuticals Inc (LGND) as of May 18, 2016, with a value of $398,080.

Latest Holdings of Melanie J Herman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LGND Ligand Pharmaceuticals Inc 2016-05-18 3,297 120.74 398,080

Holding Weightings of Melanie J Herman


Melanie J Herman Form 4 Trading Tracker

According to the SEC Form 4 filings, Melanie J Herman has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 334 shares on May 18, 2016, which brought Melanie J Herman around $40,247.

Insider Trading History of Melanie J Herman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Melanie J Herman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Melanie J Herman Ownership Network

Ownership Network List of Melanie J Herman

No Data

Ownership Network Relation of Melanie J Herman

Insider Network Chart

Melanie J Herman Owned Company Details

What does Ligand Pharmaceuticals Inc do?

Who are the key executives at Ligand Pharmaceuticals Inc?

Melanie J Herman is the Director of Accounting of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .

Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary

Over the past 18 months, Melanie J Herman made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 14,708 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .

In summary, during the past 3 months, insiders sold 39,680 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 39,680 shares. During the past 18 months, 106,227 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 99,727 shares.

Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ligand Pharmaceuticals Inc Insider Transactions

No Available Data

Melanie J Herman Mailing Address

Above is the net worth, insider trading, and ownership report for Melanie J Herman. You might contact Melanie J Herman via mailing address: 11119 North Torrey Pines Road, Suite 200, La Jolla Ca 92037.